TheraDiag SA (ALTER) - Product Pipeline Analysis and Market Research Report 2017

Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “TheraDiag SA (ALTER) - Product Pipeline Analysis, 2016 Update” to its report offerings. The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. The report analyzes all pipeline products in development for the company TheraDiag SA.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=955000

Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA is a biotechnology company that develops, manufactures, and markets in-vitro diagnostic products. The company provides product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company offers services in the autoimmune disease diagnostic market. Theradiag is headquartered in Marne LA Vallee, France.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company TheraDiag SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents:

Table of Contents 2
List of Tables 5
List of Figures 7
TheraDiag SA Company Overview 8
TheraDiag SA Company Snapshot 8
TheraDiag SA Pipeline Products and Clinical Trials Overview 8
TheraDiag SA Pipeline Analysis Overview 11
Key Facts 11
TheraDiag SA - Major Products and Services 12
TheraDiag SA Pipeline Products by Development Stage 13
TheraDiag SA Pipeline Products Overview 20
Companion Diagnostic Assay - Diabetes 20
Companion Diagnostic Assay - Diabetes Product Overview 20
Companion Diagnostic Assay - HIV/AIDS 21
Companion Diagnostic Assay - HIV/AIDS Product Overview 21
Diagnostic Kit - Autoimmune Disease 22
Diagnostic Kit - Autoimmune Disease Product Overview 22
HIV Tropism Test 23
HIV Tropism Test Product Overview 23
LTA001 LISA-TRACKER Premium Adalimumab 24

Read Full Report with TOC: http://www.marketresearchhub.com/report/theradiag-sa-alter-product-pipeline-analysis-2016-update-report.html

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:

90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Follow Us on:
Twitter: https://twitter.com/MktResearchHub
LinkedIn: https://www.linkedin.com/company/market-research-hub
Facebook: https://www.facebook.com/MarketResearchHub/

This release was published on openPR.